Themis Medicare Limited

Other

Themis Chemicals Limited

Dinesh Shantilal Patel

Shashikant Prabhudas Kurani

Sachin Dinesh Patel

Madhavlal Govindlal Patel

Madhavlal Glovindlal Patel

Shachin Dinesh Patel

The present invention relates to pharmaceutical compositions of various pharmaceutical actives, especially lyophilic and hydrophilic actives containing Diethylene glycol monoethyl ether or other alkyl derivatives thereof as a primary vehicle and/or to pharmaceutical compositions utilizing Diethylene glycol monoethyl ether or other alkyl derivatives thereof as a primary vehicle or as a solvent system in preparation of such pharmaceutical compositions. The pharmaceutical compositions of the present invention are safe, non-toxic, exhibits enhanced physical stability compared to conventional formulations containing such pharmaceutical actives and are suitable for use as injectables for intravenous and intramuscular administration, as well as for use as a preformed solution/liquid for filling in and preparation of capsules, tablets, nasal sprays, gargles, dermal applications, gels, topicals, liquid oral dosage forms and other dosage forms.

Compositions of pharmaceutical actives containing diethylene glycol monoethyl ether or other alkyl derivatives

Preparation of selective cyclooxygenase II inhibitors

An improved vane system comprising of two or more vanes being part of a spherical section related to a hub characterized in that an operative concave surface of the vane being part of the spherical section. An operative convex surface of the vane being part of a spherical section and the vane having an operative anterior lateral border with an operative posterior lateral border having a free superior tip and an inferior edge related to the hub by which the vane is angularly displaced around an axis being parallel to the velocity and the drift of the fluid.

Vane system

This invention relates to a novel pharmaceutical composition which may be administered parenterally to a mammal for the production of general anaesthesia, specifically to a limpid, stable, injectable pharmaceutical formulation of 2,6-diisopropylphenol. The formulation comprises 2,6-diisopropylphenol, a compound of the following general formula (I) ##STR1## wherein R.sub.1 and R.sub.2 can be the same or different and are hydrogen or lower alkyl group containing 1-3 carbons or acetate group and optionally water and/or one or more antioxidants.

Limpid parenteral solution of 2,6-diisoprophylphenol as an anaesthetic

Growing community of inventors

Mumbai, India

Dinesh Shantilal Patel